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Background: Pressure ulcers are insidious complications that affect approximately 2.5 million patients and account
for approximately US$11 billion in annual health care spending each year. To date we are unaware of any study
that has used a wearable patient sensor to quantify patient movement and positioning in an effort to assess
whether adherence to optimal patient turning results in a reduction in pressure ulcer occurrence.
Methods/design: This study is a single-site, open-label, two-arm, randomized controlled trial that will enroll 1812
patients from two intensive care units. All subjects will be randomly assigned, with the aid of a computer-generated
schedule, to either a standard care group (control) or an optimal pressure ulcer-preventative care group (treatment).
Optimal pressure ulcer prevention is defined as regular turning every 2 h with at least 15 min of tissue decompression.
All subjects will receive a wearable patient sensor (Leaf Healthcare, Inc., Pleasanton, CA, USA) that will detect patient
movement and positioning. This information is relayed through a proprietary mesh network to a central server for
display on a user-interface to assist with nursing care. This information is used to guide preventative care practices for
those within the treatment group. Patients will be monitored throughout their admission in the intensive care unit.
Discussion: We plan to conduct a randomized control trial, which to our knowledge is the first of its kind to use a
wearable patient sensor to quantify and establish optimal preventative care practices, in an attempt to determine
whether this is effective in reducing hospital-acquired pressure ulcers.
Trial registration: ClinicalTrials.gov, NCT02533726.Background
Pressure ulcers are insidious complications that affect
approximately 2.5 million patients and account for ap-
proximately US$11 billion in annual health care spending
each year [1]. Acutely ill patients are at risk for the devel-
opment of pressure ulcers due to immobility, reduced per-
fusion, and prolonged duration of mechanical ventilation
[2]. In 2008 the Centers for Medicare and Medicaid Ser-
vices discontinued reimbursement for facility-acquired
pressure ulcers (also known as hospital-acquired pressure
ulcers, HAPUs), as these are considered an avoidable* Correspondence: dpickham@stanfordhealthcare.org
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tremendous burden that pressure ulcers place on the
individual patient and the health care system, there is a
substantial need for improved prevention methods [3, 4].
Pressure ulcers form when there is sustained pressure,
predominately over bony prominences such as the
sacrum, heels, occiput, and shoulders. Unrelieved pressure
causes compression of cellular tissue, impaired blood flow,
and can lead to localized tissue damage and cellular death.
Pressure ulcers initially appear as areas of reddened skin
but can quickly develop into large open wounds if the
pressure is not relieved.
To prevent pressure ulcers, the currently accepted
standard of care is to turn patients at least every 2 h, day
and night. However, there are no published research
studies that support the every 2-h turning schedule inle is distributed under the terms of the Creative Commons Attribution 4.0
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mated that compliance with patient-turning protocols are
around 60 % and that a significant number of patients are
not being turned as frequently as recommended [5, 6]. In
intensive care units (ICUs), compliance to turning proto-
cols is even lower, ranging from 38 to 51 % [7, 8]. Potential
explanations for this low compliance include low prio-
ritization of turning, difficulty in monitoring a patient’s
position, ineffective turn reminders/alerts, and sub-optimal
caregiver staffing ratios – all of which hinder efforts
to prevent pressure ulcers.
To improve adherence to turning as a preventative
practice, Leaf Healthcare Inc. (Pleasanton, CA, USA) has
developed a patient-monitoring system designed to
optimize patient-turning practices. This system is com-
posed of a small, single, wearable patient sensor that
adheres to a patient’s chest, similar to a standard telem-
etry electrode. The sensor communicates wirelessly to a
central monitoring station about the patient’s current
position (upright, supine/back, right side, left side) and
time-to-next-turn. Data for all patients are displayed on
a User-Dashboard, allowing staff to easily identify pa-
tients who are in need of turning. The system also allows
caregivers to identify restricted positions due to existing
pressure ulcers or surgical wounds, as well as to create
personalized turning protocols, by varying the degree of
turn angle and/or tissue decompression thresholds.
Two single-center clinical studies have been completed
using the monitoring equipment. A small first-in-human
Institutional Review Board (IRB)-approved study was
performed to test the feasibility of the patient sensor,
mesh network, and monitoring system, and to collect
baseline data regarding turning protocol compliance.
After this, a second single-center IRB-approved clinical
study tested the efficacy, usability, and safety of the
monitoring system (ClinicalTrials.gov #NCT02005692).
After implementation of the system, compliance to pa-
tient turning was reported to have increased significantly
from 64 to 98 % [9].
To date, the study team are unaware of any study that
has used a wearable patient sensor to quantify patient
movement and positioning, in an effort to assess whether
adherence to optimal patient turning results in a reduc-
tion in pressure ulcer occurrence. As such, the following
protocol describes the study to be conducted to evaluate
whether optimal patient turning, defined as regular turn-
ing every 2 h with at least 15 min of tissue decompression,
reduces HAPUs in acutely ill patients.
Methods/design
Design
This study is a single-site, open-label, two-arm, randomized
controlled trial. As this is an open-label trial, a short obser-
vation pilot study will be undertaken during installationand testing of the patient-monitoring system to account for
potential observer bias (the Hawthorne effect). The true in-
tent of the technology will be obfuscated to patients and
clinical staff in an effort to record baseline data that more
accurately represent current turning practices within these
units. These pilot data will also be used to determine mini-
mum turning thresholds for the main study and to assess
the representativeness of the main study’s control group. A
convenient sample of 25 subjects will be enrolled from each
participating unit.
Randomization
All subjects will be randomly assigned, with the aid of a
computer-generated schedule, to receive either standard
care (control group) or optimal pressure ulcer preventa-
tive care (treatment group). To minimize the risk of pre-
dicting the treatment assignment, randomization is
performed in permuted blocks of two, four, and six, with
random variation of block sizes. To minimize bias at the
patient level, randomization is further stratified by unit
of admission and admitting service, either medicine or
surgery (Fig. 1). Once randomized, each subject will
receive a nominal study identification number based on
the unit of admission and admitting service. The lowest
available number will be provided to each subject in se-
quential order.
Study population
This study will enroll all patients admitted to two ICUs.
These patients are critically ill with exacerbations of
acute and chronic medical conditions, or are receiving
aggressive post-surgical care for neurological, cardiac, or
trauma-related conditions. They typically have altered
levels of consciousness and are dependent on clinical
staff for activities of daily living. Due to immobility and
other clinical factors these patients are at high risk for
developing pressure ulcers. As it is infeasible to gain
written consent from this patient population and, due to
the minimal risk of the study procedures, a waiver of
individual authorization has been granted by Stanford
University’s IRB (see Ethics approval section). Therefore,
all patients over the age of 18 years admitted to one of
the two ICUs will be enrolled in the study. Patients
under 18 years of age, those with a known allergy to skin
adhesive, or who possess a physical barrier preventing
the application of the monitoring sensor, are not eligible
for inclusion.
Recruitment/Intervention
Upon admission to a study unit and as part of standard
care, the patient receives a complete “head-to-toe” as-
sessment of their skin. This is performed by two regis-
tered nurses (RNs). Any pre-existing pressure ulcer that

















Fig. 1 Randomization schema. Stratification by unit and admitting service team
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admission procedures are performed, and within the first
hour of arrival, nursing staff will place a patient sensor
(Leaf Healthcare, Pleasanton, CA, USA) in a predefined
location on the patient’s chest (Fig. 2). If an exclusion
condition is present, this will be documented and the
patient will not be enrolled in the study and will not re-
ceive a patient sensor.
For patients included in the study, the unit secretary
will provide nursing staff with a patient sensor after
associating the sensor’s serial number with the patient’s
specific information. This is automatically derived from
an Admission-Discharge-Transfer (ADT) data stream
communicating directly with the Leaf Patient Monitor-
ing System. At this time the unit secretary will open an
envelope, pre-filled with the computer-generated random-
ized group allocation. A patient sticker will be affixed to
the back of the randomization card and stored in a secure
location for later retrieval and verification of correct
randomization and enrollment. The patient will then be
enrolled in either a treatment or control group.When a subject is enrolled in the treatment group, the
User-Dashboard will be turned “on,” allowing the sensor
to communicate the patient’s position and movements
(Fig. 3). The clinical team will review this information
and be guided by visual displays to provide pressure
ulcer-prevention turning practices. With the use of the
User-Dashboard, nurses will be prompted to perform
pressure ulcer preventative care, namely patient turning
with satisfactory tissue decompression for 15 min, at
least every 2 h (optimal). If a patient does not receive
the full time of tissue decompression, the Leaf Patient
Monitoring System automatically adjusts, proportionally
reducing the time-to-next-turn. For example, if the pa-
tient was on their back and moved to their right side,
but returned to their back within 7–8 min, the time-to-
next-turn will be adjusted reciprocally from 2 h to 1 h.
This ensures that patients receive at least 15 min of tis-
sue decompression every 2 h.
If the subject is enrolled in the control group, the unit
secretary will turn the User-Dashboard “off” by selecting
the “control patient” check-box in the Leaf Patient
Fig. 2 Location of patient-monitoring sensor. *Used with permission
from Leaf Healthcare, Inc.
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tion off and therefore not display any information to the
User-Dashboard. Patients in the control group will con-
tinue to receive standard care practices, that is, pressure
ulcer-prevention activities initiated by nurses using their
usual care routines. Nursing care will not be “optimized”
by the Leaf Patient Monitoring System, with the system
withholding any data related to turning frequency, pos-
ition schedule, and decompression time. The patient
sensor will continue to collect these data for the pur-
poses of research analysis only.
Each patient’s participation within the study begins
within the first hour of arrival to a study unit and ends
upon discharge or transfer from the study unit. Upon
leaving the unit, the patient sensor will be removed andthe patient will be discharged automatically from the
Leaf Patient Monitoring System.Technology
The Leaf Patient Monitoring System is a proprietary sys-
tem developed by Leaf Healthcare Inc. (Pleasanton, CA,
USA) [10]. The Leaf Patient Monitoring System is a
wireless monitoring system that enables personalized
turning protocols. A wireless, wearable, single-patient
sensor communicates a patient’s body position and move-
ment, through a proprietary mesh network of relay anten-
nas placed throughout the study units to a central
monitoring system (Fig. 4). The Leaf Turn Management
System accesses an industry standard Health Level Seven
International (HL7)-ADT data stream. This allows for
simplified and accurate patient enrollment and seamless
tracking of patient movement throughout the study units.
For data security, all data generated from the Leaf Patient
Monitoring System are transferred and stored within the
institution’s firewall to secure servers. The Leaf Turn
Management System is the User-Dashboard that displays
an individual patient’s positioning and movement data to
the clinical team.Data management
Proprietary turning data will be acquired from the Leaf
Patient Monitoring System. Compliance to preventative
turning care will be defined by two measures. The first
will sum the overall time the patient is overdue for turn-
ing care, divided by the total monitoring time, and will
be reported as a percentile of time. For example, if a pa-
tient was on the unit for 4 h and did not receive pre-
ventative turning care at the second hour, but instead at
the third hour (1 h overdue), then the patient’s care was
in compliance for 3 of the 4 h of their length of stay.
This would, therefore, represent a time in compliance of
75 %. If they received the turn on schedule, the compli-
ance would be at 100 %. The second measure will divide
a patient’s length of stay into 2 h turning blocks. In the
above example, if the patient was turned once in their
4 h stay, compliance to turning would equal 50 %. Al-
though we believe that the time in compliance is more
appropriate than the proportion of turns within 2 h
blocks, we will test and report on both measures as the
latter reflects current clinical care practices.Pressure ulcer staging
The National Pressure Ulcer Advisory Panel (NPUAP)
staging criteria will be used to stage all HAPUs [11]. Sta-
ging will be completed by an expert RN blinded to the
patients’ study allocation. Adjudication will occur with
the study team for any wounds that are difficult to stage.
Fig. 3 User-Dashboard – Leaf Patient Monitoring Interface. *Used with permission from Leaf Healthcare, Inc.
Pickham et al. Trials  (2016) 17:190 Page 5 of 8 Stage I, non-blanchable erythema: intact skin with
non-blanchable redness of a localized area usually
over a bony prominence. Darkly pigmented skin
may not have visible blanching; its color may differ
from the surrounding area. The area may be painful,
firm, soft, warmer or cooler as compared to adjacent
tissue. Category I may be difficult to detect in
individuals with dark skin tones. This stage may
indicate “at risk” persons
 Stage II, partial thickness skin loss: partial-thickness
loss of dermis presenting as a shallow, open ulcer
with a red-pink wound bed, without slough. This
may also present as an intact or open/ruptured
serum-filled or sero-sanginous-filled blister. ItFig. 4 Wearable patient sensor communication network. *Used with permissipresents as a shiny or dry, shallow ulcer without
slough or bruising*. This category should not be
used to describe skin tears, tape burns,
incontinence-associated dermatitis, maceration or
excoriation. *Bruising indicates deep tissue injury
 Stage III, full-thickness skin loss: full-thickness tissue
loss. Subcutaneous fat may be visible but bone,
tendon or muscle are not exposed. Slough may be
present but does not obscure the depth of tissue
loss. This may include undermining and tunneling.
The depth of a category/stage III pressure ulcer
varies by anatomical location. The bridge of the
nose, ear, occiput and malleoli have no (adipose)
subcutaneous tissue and category/stage III ulcerson from Leaf Healthcare, Inc.
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adiposity can develop extremely deep category/
stage III pressure ulcers. Bone/tendon is not visible
or directly palpable
 Stage IV, full-thickness tissue loss: full-thickness
tissue loss with exposed bone, tendon or muscle.
Slough or eschar may be present. This stage often
includes undermining and tunneling. The depth
of a category/stage IV pressure ulcer varies by
anatomical location. The bridge of the nose, ear,
occiput and malleoli have no (adipose) subcutaneous
tissue and these ulcers can be shallow. Category/
stage IV ulcers can extend into muscle and/or
supporting structures (e.g., fascia, tendon or joint
capsule) making osteomyelitis or osteitis likely to
occur. Exposed bone/muscle is visible or directly
palpable
Data collection
Patient demographics and clinical data will be obtained
from the Stanford Translational Research Integrated
Database Environment (STRIDE). STRIDE is a clinical
data warehouse that is maintained by the Stanford Uni-
versity School of Medicine and is updated in near real
time directly from the EMR used at Stanford Health
Care. All data generated from the study will be managed
and stored using REDCap electronic data capture tools,
hosted by Stanford University. REDCap (Research Elec-
tronic Data Capture) is a secure, web-based application
designed to support data capture for research studies [12].
Study endpoints
Primary
The following endpoints will be evaluated:
 Difference in compliance rates with preventative
turning practices between the treatment and control
groups, as continuously measured by the Leaf
Patient Monitoring System during the patients’
ICU stay
 Difference in the proportion of HAPUs between the
treatment and control groups
Secondary
Secondary measures are to:
 Evaluate and describe, any differences identified
in hospital-acquired pressure ulcer rates and
stages between medical and surgical patient
groups
 Develop explanatory models of contributing clinical
factors to HAPUs for the three groups: all ICU
patients, medical patients only, and surgical
patients onlySample size calculation
Using a two-sided Z test of the difference between pro-
portions with 80 % power and a 5 % significance level, a
sample size of 1812 patients, 906 in each group, will be
sufficient to detect a clinically important difference of
50 % between the groups in the rate of HAPUs. This as-
sumes that a 50 % difference represents a change from a
prevalence rate of 5 % for pressure ulcers in the control
group, to a rate of 2.5 % for pressure ulcers in the treat-
ment group. Conservatively, with an estimated enrollment
of 200 subjects per month, study enrollment is expected
to be between 7 and 10 months’ duration.
Statistical analysis
Data analysis will be conducted using IBM SPSS Predict-
ive Analytics Software (v20, Armonk, NY, USA), after data
cleaning and organization within Excel 2010 (Microsoft,
Seattle, WA, USA). A consultant statistician, external to
the study team and trained in quantitative methods will
oversee data analyses.
Descriptive analysis
Demographic and clinical characteristics will be summa-
rized for each treatment group and reported. Frequencies
will be determined for count data, such as the proportion
of patients with pressure ulcers, and descriptive summar-
ies will be used for continuous data, such as percentage of
compliance time. Measures of central tendency (mean,
standard deviation, median, minimum, and maximum
values) will also be reported.
Primary endpoint
An independent-samples Student’s t test will be used to
evaluate for differences in preventative turning compli-
ance between the two groups. To test for differences in
pressure ulcer rates between the treatment groups, a 2 × 2
table with chi-square statistic will be used. To further
evaluate for differences in pressure ulcer rates between
treatment groups over time, a Kaplan-Meier survival ana-
lysis with log-rank test will be used. For all analyses, tests
are deemed to be significant if significance is less than
p <0.05. Device-related pressure ulcers from catheters
or tubes are generally unrelated to turning and are not
included in this analysis.
Secondary endpoint
To test for differences in HAPUs between patients based
on admitting service (medical or surgical), a Kruskal-
Wallis rank test will be used. Stages of pressure ulcers
(based on NPUAP staging criteria) will represent the
ranks to be measured. A difference will exist if the sig-
nificance level of the test statistic is p <0.05.
In creating explanatory models, multivariate logistic
regression will be used. First, univariate testing of each
Pickham et al. Trials  (2016) 17:190 Page 7 of 8variable in relationship to the endpoint (hospital-ac-
quired pressure ulcer) will be performed. Only variables
having a maximum significance with the endpoint of
p <0.20 will be included in the multivariate model.
Age and sex will be reintroduced to the models if they fail
to meet the inclusion criteria and all other variables will
be entered into the model in a forward stepwise fashion.
This will be rerun until only significant variables remain.
Three logistic regression models will be constructed: all
ICU patients, only medical patients, and only surgical
patients.
Ethics approval
The study protocol was reviewed and approved by the
Stanford University Institutional Review Board (IRB).
Due to the study procedures and patient acuity, a waiver
of authorization was granted for enrollment. This study
is registered with ClinicalTrials.gov, NCT02533726; how-
ever, it is not open to public enrollment.
Discussion
This study investigates the effect of optimal turning,
defined as patient turning every 2 h with at least 15 min
of tissue decompression, on reducing HAPUs. It com-
pares outcomes in the treatment group with a control
group. The treatment group consists of patients receiv-
ing clinical care that is optimized by the Leaf Patient
Monitoring System (Leaf Health Care, Pleasanton, CA,
USA). This system monitors patient positioning and ad-
vises when a patient turn is due, based on preset criteria,
and allows for personalized care practices.
The strength of this study is its robust design. A
randomized control trial is planned, which to our know-
ledge is the first of its kind to use a wearable patient
sensor to quantify and establish optimal preventative
care practices, in an attempt to determine whether these
are effective in reducing HAPUs. Prior studies have used
an assortment of technical solutions, including environ-
mental and mattress sensors measuring body temperature,
estimated body position, and surface compression [13].
However, these studies have consistently failed to assess
outcomes: specifically, whether these approaches actually
reduce HAPUs. In this study, any positive results will be
of immediate benefit as much of the study’s methodolo-
gies maintain standard care practices. Therefore, positive
findings will be readily translated into clinical practices.
However, there are important challenges in this study.
The first challenge is maintaining group assignment. We
plan to randomize patients across two ICUs, involving
58 beds and over 300 RNs. Over the course of the ICU
length of stay a patient may receive care from many
RNs. During the study period it is very likely that an in-
dividual nurse will care for patients in both treatment
and control groups. Therefore, there is a risk that nurseswill transfer and apply knowledge of optimal turning
practices between groups. In addition, although nurses
remain within the patient’s room for their entire shift, it
is plausible that communication regarding prevention
care practices occurs during breaks, or with nurses in
adjacent patient rooms. To identify and account for po-
tential bias, a small pilot study will be conducted prior
to the primary study to establish baseline adherence
rates. Twenty-five patients from each unit will receive
unmarked sensors from the research team. Nurses will
be masked as to the sensors’ true intent and the sensors
will collect the same patient-positioning information as
the primary study. These data will be used to compare
data derived from the control group, to assess for any
potential cross-over or observer bias effects.
Another challenge within this study is the number of
software steps required to ensure accurate function,
feedback and group assignment. The clinical care team
receive data from the User-Dashboard about a patient’s
position and time-to-next-turn. However, the system
requires that the unit secretary accurately enters the
correct group assignment. Also, due to the complexity
of clinical software applications, accessing the User-
Dashboard is a two-step process for staff. Staff must sep-
arately open the software application in addition to the
EMR. Once activated, the software reduces the technical
burden on clinical staff as the User-Dashboard ac-
cesses a HL7-ADT feed. This automatically provides
complete patient demographic data and tracks patient
location throughout their ICU length of stay, minim-
izing the need for staff to continually update this
information.
To further ensure that clinical staff complete study
procedures, daily monitoring of study units will occur.
To ensure that unit secretaries are correctly assigning pa-
tients based on the computer-generated randomization
schedule, a patient sticker will be applied to the back of
the randomization card and placed in a secured box at the
point of enrollment. On a regular schedule these data will
be collected, stored, and cross-referenced with the patient
allocation entered into the Leaf Patient Monitoring
System.
Finally, this study brings together research personnel
from both clinical and technical teams of a major aca-
demic health system, working together to implement a
large clinical trial within a complex care environment.
As organizations focus on improving clinical care envi-
ronments, building efficiencies in clinical research and
in adopting and testing innovative technologies is im-
perative in improving health care delivery and clinical
outcomes for patients.
Trial status
At time of submission this trial is open to enrollment.
Pickham et al. Trials  (2016) 17:190 Page 8 of 8Abbreviations
ADT: Admission-Discharge-Transfer; HAPU: Hospital-Acquired Pressure Ulcer;
HL7: Health Level Seven International; ICU: Intensive Care Unit; PU: Pressure
Ulcer; EMR: Electronic Medical Record; RN: Registered Nurse.
Competing interests
Leaf Healthcare, Inc. was co-founded by Dr. Barrett Larson MD, a physician
employed at Stanford University. Leaf Healthcare, Inc. is a co-sponsor of this
study and provides monitoring hardware, proprietary software, and technical
support.
Authors’ contributions
All authors contributed to the development and design of the protocol
(DP, BB, KE, JS, ML, and BM). DP, BB, and KE developed the analysis plan and
applied for institutional support. DP has drafted the manuscript with critical
input from all other authors who have read and approved the final
manuscript (BB, KE, JS, ML, and BM).
Acknowledgements and Funding
Authors would like to acknowledge the support of Nancy Lee, VP Patient
Care Services and Dr. Pravene Nath, Chief Information Officer, Stanford
Health Care. We also acknowledge the direction and support of Dr. Chris
Furmanski, Director of Innovation, Rajiv Ramdeo (Informational Technology),
the staff and management of the E2 and E29 clinical ICUs, including unit
managers, Maureen Fay and Kathy Seppala, as well as Chris Nguyen, Alex
Kreis, Michael Pihulic, Annemari Cooley, and Mark Smith from Leaf
Healthcare, Inc. This study is co-sponsored by Stanford Health Care and Leaf
Healthcare, Inc.
Author details
1General Medical Disciplines, Stanford Medicine, Menlo Park, CA, USA. 2Office
of Research, Patient Care Services, Stanford Health Care, Stanford, CA, USA.
3Digital Health, Stanford Health Care, Stanford, CA, USA. 4Patient Care
Services, Stanford Health Care, Stanford, CA, USA.
Received: 4 February 2016 Accepted: 25 March 2016
References
1. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory
Panel, Pan Pacific Pressure Injury Alliance. In: Haesler E, editor. Prevention
and treatment of pressure ulcers: clinical practice guideline. Perth:
Cambridge Media; 2014.
2. Cooper KL. Evidence-based prevention of pressure ulcers in the intensive
care unit. Crit Care Nurse. 2013;33(6):57–66. doi:10.4037/ccn2013985.
published Online First: Epub Date.
3. AHRQ. Preventing pressure ulcers in hospitals: a toolkit for improving quality
of care. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
4. Vangilder C, MacFarlane G, Meyer S. Results of nine international
pressure ulcer prevention surveys: 1998–2005. Ostomy Wound Manag.
2008;54(2):40–54.
5. Gunningberg L. Are patients with or at risk of pressure ulcers allocated
appropriate prevention measures? Int J Nurs Pract. 2005;11(2):58–67.
doi:10.1111/j.1440-172X.2005.00503.x. published Online First: Epub Date.
6. Lyder CH, Preston J, Grady JN, et al. Quality of care for hospitalized
medicare patients at risk for pressure ulcers. Arch Intern Med. 2001;161(12):
1549–54. doi:10.1001/archinte.161.12.1549. published Online First: Epub Date.
7. Krishnagopalan S, Johnson EW, Low LL, et al. Body positioning of
intensive care patients: clinical practice versus standards*. Crit Care Med.
2002;30(11):2588–92.
8. Schallom L, Metheny NA, Stewart J, et al. Effect of frequency of manual
turning on pneumonia. Am J Crit Care. 2005;14(6):476–8.
9. Tarver C, Schutt S, Pezzani M. We’re sensing you! A multi-phase clinical trial
examining innovative technology to improve patient-turning compliance.
Paper presented at the ANCC National Magnet Conference. Dallas, Texas.
2014.
10. Leaf Healthcare, Inc. Solution overview: the next step in wireless patient
monitoring: Leaf Healthcare Inc., 2014. accessed February 12th, http://
leafhealthcare.com/pdfs/LH_SolutionOverview_1560AA_060214.pdf
11. National Pressure Ulcer Advisory Panel Pressure Ulcer Stages. Secondary
NPUAP pressure ulcer stages.12. Harris P, Taylor R, Thielke R, et al. Research Electronic Data Capture
(REDCap) – A meta-driven methodology and workflow process for
providing translational research informatics support. J Biomed Inform.
2009;42(2):377–81.
13. Marchione FG, Araújo LMQ, Araújo LV. Approaches that use software to
support the prevention of pressure ulcer: a systematic review. Int J Med
Inform. 2015;84(1):725–36.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
